يعرض 101 - 120 نتائج من 173,387 نتيجة بحث عن '(((( 5 ng decrease ) OR ( 0 0 decrease ))) OR ( 5 ((a decrease) OR (nn decrease)) ))', وقت الاستعلام: 1.00s تنقيح النتائج
  1. 101
  2. 102
  3. 103
  4. 104
  5. 105

    S1 Data - حسب Mahmoud A. Alomari (14780446)

    منشور في 2023
    الموضوعات:
  6. 106
  7. 107
  8. 108
  9. 109
  10. 110
  11. 111
  12. 112
  13. 113

    The decreasing rates of V<sub>p</sub> with temperature. حسب Nazlı Tunar Özcan (14833635)

    منشور في 2023
    "…In this study, P-wave velocity (V<sub>p</sub>), Brazilian tensile strength (σ<sub>t</sub>), uniaxial compression strength (σ<sub>c</sub>) of Çankırı rock salt were investigated under different temperatures ranging from 20°C to 250°C since the temperature is a factor that causes changes in some physical and geo-mechanical properties of rocks. …"
  14. 114
  15. 115
  16. 116

    Summary of trend results based on Mann-Kendall test and Sen’s slope estimator for the 34 weather stations (arranged according to administrative division, in bold) for the dry season (November to April) (p < 0.10 = *, p < 0.05 = **, p < 0.01 = ***,—sign indicates decreasing trend). حسب Mohammed Mainuddin (8723352)

    منشور في 2022
    "…<p>Summary of trend results based on Mann-Kendall test and Sen’s slope estimator for the 34 weather stations (arranged according to administrative division, in bold) for the dry season (November to April) (p < 0.10 = *, p < 0.05 = **, p < 0.01 = ***,—sign indicates decreasing trend).…"
  17. 117
  18. 118
  19. 119
  20. 120

    Table_5_NOTCH1 mutation associates with impaired immune response and decreased relapse-free survival in patients with resected T1-2N0 laryngeal cancer.docx حسب Xiao-yang Gong (13103400)

    منشور في 2022
    "…</p>Results<p>To the best to our knowledge, we present for the first time an overview of the genomic mutation spectrum of early-stage laryngeal cancers. A total of 469 genomic alterations were detected in 211 distinct cancer-relevant genes, and the genes found to be mutated in more than five patients (>10%) included tumor protein p53 (TP53, 78.5%), FAT atypical cadherin 1 (FAT1, 26%), LDL receptor related protein 1B (LRP1B, 19%), cyclin dependent kinase inhibitor 2A (CDKN2A, 17%), tet methylcytosine dioxygenase 2 (TET2, 17%), notch receptor 1 (NOTCH1, 12%) and neuregulin 1 (NRG1, 12%). …"